161 related articles for article (PubMed ID: 21351101)
1. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis.
Yazbeck R; Howarth GS; Butler RN; Geier MS; Abbott CA
J Cell Physiol; 2011 Dec; 226(12):3219-24. PubMed ID: 21351101
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase expression during experimental colitis in mice.
Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA
Inflamm Bowel Dis; 2010 Aug; 16(8):1340-51. PubMed ID: 20186930
[TBL] [Abstract][Full Text] [Related]
3. Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV.
Geier MS; Tenikoff D; Yazbeck R; McCaughan GW; Abbott CA; Howarth GS
J Cell Physiol; 2005 Aug; 204(2):687-92. PubMed ID: 15754331
[TBL] [Abstract][Full Text] [Related]
4. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
[TBL] [Abstract][Full Text] [Related]
6. M3 muscarinic receptor-deficient mice retain bethanechol-mediated intestinal ion transport and are more sensitive to colitis.
Hirota CL; McKay DM
Can J Physiol Pharmacol; 2006 Nov; 84(11):1153-61. PubMed ID: 17218980
[TBL] [Abstract][Full Text] [Related]
7. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
8. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
9. Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5.
Deguchi Y; Andoh A; Inatomi O; Araki Y; Hata K; Tsujikawa T; Kitoh K; Fujiyama Y
Int J Mol Med; 2005 Oct; 16(4):605-8. PubMed ID: 16142393
[TBL] [Abstract][Full Text] [Related]
10. Knock-out of β-glucosidase 2 has no influence on dextran sulfate sodium-induced colitis.
Scharl M; Leucht K; Frey-Wagner I; Zeitz J; Hausmann M; Fischbeck A; Liebisch G; Kellermeier S; Pesch T; Arikkat J; Schmitz G; Fried M; Yildiz Y; Rogler G
Digestion; 2011; 84(2):156-67. PubMed ID: 21576963
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis.
Farooq SM; Stillie R; Svensson M; Svanborg C; Strieter RM; Stadnyk AW
J Pharmacol Exp Ther; 2009 Apr; 329(1):123-9. PubMed ID: 19131582
[TBL] [Abstract][Full Text] [Related]
12. Dextran sulfate sodium induces pan-gastroenteritis in rodents: implications for studies of colitis.
Elsheikh W; Flannigan KL; McKnight W; Ferraz JG; Wallace JL
J Physiol Pharmacol; 2012 Oct; 63(5):463-9. PubMed ID: 23211300
[TBL] [Abstract][Full Text] [Related]
13. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice.
Katada K; Yoshida N; Suzuki T; Okuda T; Mizushima K; Takagi T; Ichikawa H; Naito Y; Cepinskas G; Yoshikawa T
Inflamm Res; 2008 Feb; 57(2):84-91. PubMed ID: 18288458
[TBL] [Abstract][Full Text] [Related]
14. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
15. Effect of processed Scutellaria baicalensis on dextran sulfate sodium-induced colitis in mice.
Choi YA; Kang OH; Park HJ; Tae J; Kim DK; Kang CS; Choi SC; Yun KJ; Choi SJ; Nah YH; Kim YH; Bae KH; Lee YM
Int J Mol Med; 2005 Oct; 16(4):667-72. PubMed ID: 16142402
[TBL] [Abstract][Full Text] [Related]
16. Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.
Schmidt N; Gonzalez E; Visekruna A; Kühl AA; Loddenkemper C; Mollenkopf H; Kaufmann SH; Steinhoff U; Joeris T
Gut; 2010 Jul; 59(7):896-906. PubMed ID: 20581238
[TBL] [Abstract][Full Text] [Related]
17. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice.
Villegas I; Alarcón de la Lastra C; Orjales A; La Casa C
Int Immunopharmacol; 2003 Dec; 3(13-14):1731-41. PubMed ID: 14636824
[TBL] [Abstract][Full Text] [Related]
18. Mucosal function in rat jejunum and ileum is altered by induction of colitis.
Amit-Romach E; Reifen R; Uni Z
Int J Mol Med; 2006 Oct; 18(4):721-7. PubMed ID: 16964428
[TBL] [Abstract][Full Text] [Related]
19. [Effect of balsalazide on intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice].
Liu XC; Mei Q; Xu JM; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):193-6. PubMed ID: 19296261
[TBL] [Abstract][Full Text] [Related]
20. Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity.
Diaz-Granados N; Howe K; Lu J; McKay DM
Am J Pathol; 2000 Jun; 156(6):2169-77. PubMed ID: 10854237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
